Ceptaz Side Effects Center

Last updated on RxList: 11/1/2021
Ceptaz Side Effects Center

What Is Ceptaz?

Ceptaz (ceftazidime) Injection is an antibiotic used to treat infections caused by certain types of bacteria. Ceptaz is available in generic form.

What Are Side Effects of Ceptaz?

Common side effects of Ceptaz include:

Dosage for Ceptaz

The recommended dosage of Ceptaz is 1 gram every 8 to 12 hours.

What Drugs, Substances, or Supplements Interact with Ceptaz?

Furosemide, chloramphenicol, Clinitest tablets, Benedict's solution, and Fehling's solution may interact with Ceptaz.

Ceptaz During Pregnancy or Breastfeeding

Tell your doctor all medications you take. Use caution if you have colitis and take Ceptaz. If you are pregnant only use Ceptaz if clearly needed. Do not take Ceptaz if you are breastfeeding.

Additional Information

Our Ceptaz (ceftazidime) Injection Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

QUESTION

About how much does an adult human brain weigh? See Answer
Ceptaz Consumer Information

3 pharmacies near 20147 have coupons for ceptaz (Brand Names:Ceptaz for 1-5GM-%(50ML))

Harris Teeter Pharmacy
Harris Teeter Pharmacy
$147.07

with free coupon

View Coupon
CVS Pharmacy
CVS Pharmacy
$149.89

with free coupon

View Coupon
Walgreens
Walgreens
$150.82

with free coupon

View Coupon

Get emergency medical help if you have signs of an allergic reaction (hives, itching, feeling light-headed, wheezing, difficult breathing, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling).

Call your doctor at once if you have:

  • severe stomach pain, diarrhea that is watery or bloody (even if it occurs months after your last dose);
  • pale or yellowed skin, dark colored urine, fever, or weakness;
  • confusion, hallucinations, severe weakness;
  • involuntary muscle movement;
  • seizure (black-out or convulsions); or
  • a cold feeling, discoloration, or skin changes in your fingers.

Common side effects may include:

  • allergic reaction;
  • numbness, tingling, burning pain;
  • headache, dizziness;
  • nausea, vomiting, diarrhea, stomach pain; or
  • signs of a fungal infection--sores or white patches in your mouth or throat, vaginal itching or discharge.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Ceptaz (Ceftazidime)

SLIDESHOW

Digestive Disorders: Common Misconceptions See Slideshow
Ceptaz Professional Information

SIDE EFFECTS

The following adverse effects from clinical trials were considered to be either related to ceftazidime therapy or were of uncertain etiology. The most common were local reactions following IV injection and allergic and gastrointestinal reactions. No disulfiramlike reactions were reported.

Local Effects, reported in fewer than 2% of patients, were phlebitis and inflammation at the site of injection (1 in 69 patients).

Hypersensitivity Reactions, reported in 2% of patients, were pruritus, rash, and fever. Immediate reactions, generally manifested by rash and/or pruritus, occurred in 1 in 285 patients. Toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme have also been reported with cephalosporin antibiotics, including ceftazidime. Angioedema and anaphylaxis (bronchospasm and/or hypotension) have been reported very rarely.

Gastrointestinal Symptoms, reported in fewer than 2% of patients, were diarrhea (1 in 78), nausea (1 in 156), vomiting (1 in 500), and abdominal pain (1 in 416). The onset of pseudomembranous colitis symptoms may occur during or after treatment (see WARNINGS).

Central Nervous System Reactions (fewer than 1%) included headache, dizziness, and paresthesia. Seizures have been reported with several cephalosporins, including ceftazidime. In addition, encephalopathy, coma, asterixis, neuromuscular excitability, and myoclonia have been reported in renally impaired patients treated with unadjusted dosage regimens of ceftazidime (see PRECAUTIONS: General).

Less Frequent Adverse Events (fewer than 1%) were candidiasis (including oral thrush) and vaginitis.

Hematologic: Rare cases of hemolytic anemia have been reported.

Laboratory Test Changes noted during ceftazidime clinical trials were transient and included: eosinophilia (1 in 13), positive Coombs' test without hemolysis (1 in 23), thrombocytosis (1 in 45), and slight elevations in one or more of the hepatic enzymes, aspartate aminotransferase (AST, SGOT) (1 in 16), alanine aminotransferase (ALT, SGPT) (1 in 15), LDH (1 in 18), GGT (1 in 19), and alkaline phosphatase (1 in 23). As with some other cephalosporins, transient elevations of blood urea, blood urea nitrogen, and/or serum creatinine were observed occasionally. Transient leukopenia, neutropenia, agranulocytosis, thrombocytopenia, and lymphocytosis were seen very rarely.

Postmarketing Experience With Ceptaz (ceftazidime) Products

In addition to the adverse events reported during clinical trials, the following events have been observed during clinical practice in patients treated with CEPTAZ (ceftazidime) and were reported spontaneously. For some of these events, data are insufficient to allow an estimate of incidence or to establish causation.

General: Anaphylaxis; allergic reactions, which, in rare instances, were severe (e.g., cardiopulmonary arrest); urticaria; pain at injection site.

Hepatobiliary Tract: Hyperbilirubinemia, jaundice.

Renal and Genitourinary: Renal impairment.

Cephalosporin-Class Adverse Reactions: In addition to the adverse reactions listed above that have been observed in patients treated with ceftazidime, the following adverse reactions and altered laboratory tests have been reported for cephalosporin-class antibiotics:

Adverse Reactions: Colitis, toxic nephropathy, hepatic dysfunction including cholestasis, aplastic anemia, hemorrhage.

Altered Laboratory Tests: Prolonged prothrombin time, false-positive test for urinary glucose, pancytopenia.

Read the entire FDA prescribing information for Ceptaz (Ceftazidime)

© Ceptaz Patient Information is supplied by Cerner Multum, Inc. and Ceptaz Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors